Glucose Health's GlucoDown Sales Surge Over 120% YOY, Retail Distribution Doubles
Summary
Glucose Health, Inc. announced significant sales growth for its GlucoDown product, with one major national pharmacy retailer seeing over 120% year-over-year volume increase in the first half of 2026. Another national drug store chain reported a 135.7% sales increase for the same period. The company also nearly doubled its retail distribution in one chain, expanding from 1,250 to approximately 2,500 locations. These strong sales trends and expanded footprint have led the company to raise its growth outlook for 2026, indicating strong product adoption and market momentum for this micro-cap company.
At the time of this announcement, GLUC was trading at $0.50 on OTC in the Life Sciences sector, with a market capitalization of approximately $8.4M. The 52-week trading range was $0.02 to $0.67. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.